Table 2.
N | Prevalence, % (95% CI) | 95% prediction interval | |
---|---|---|---|
Patients described as Black or African American | |||
Patients (k = 9) | 40,751 | 9.5 (4.7 to 18.3) | 1.0 to 52.3 |
Sensitivity analysis (k = 7) | 38,923 | 10.0 (4.4 to 21.1) | 1.0 to 55.8 |
Paired observations (k = 13) | 111,779 | 6.0 (3.9 to 9.3) | 1.1 to 26.9 |
Patients described as Asian, Latinx, Indigenous, multiracial, or other race or ethnicity | |||
Patients (k = 8)* | 39,336 | 8.9 (4.0 to 18.4) | 0.8 to 54.5 |
Sensitivity analysis (k = 6)† | 35,579 | 11.1 (4.5 to 24.7) | 0.9 to 62.0 |
Paired observations (k = 8)‡ | 202,253 | 3.4 (1.4 to 8.1) | 0.2 to 34.6 |
Patients described as White or Caucasian | |||
Patients (k = 8) | 127,377 | 6.4 (3.3 to 11.8) | 0.9 to 33.9 |
Sensitivity analysis (k = 6) | 119,419 | 7.3 (3.6 to 14.2) | 1.1 to 35.6 |
Paired observations (k = 13) | 418,473 | 2.5 (1.5 to 4.3) | 0.3 to 16.9 |
k number of studies
*Eight studies reporting 19 prevalence estimates
†Six studies reporting 15 prevalence estimates
‡Eight studies reporting 20 prevalence estimates